These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36583475)

  • 1. MicroRNA 200a as a histologically independent marker for meningioma recurrence: Results of a four microRNA panel analysis in meningiomas.
    Urbschat S; Landau B; Bewersdorf NC; Schuster C; Wagenpfeil G; Schulz-Schaeffer WJ; Oertel J; Ketter R
    Cancer Med; 2023 Apr; 12(7):8433-8444. PubMed ID: 36583475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulated microRNA-200a in meningiomas promotes tumor growth by reducing E-cadherin and activating the Wnt/beta-catenin signaling pathway.
    Saydam O; Shen Y; Würdinger T; Senol O; Boke E; James MF; Tannous BA; Stemmer-Rachamimov AO; Yi M; Stephens RM; Fraefel C; Gusella JF; Krichevsky AM; Breakefield XO
    Mol Cell Biol; 2009 Nov; 29(21):5923-40. PubMed ID: 19703993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Meningioma Patients at High Risk of Tumor Recurrence Using MicroRNA Profiling.
    Slavik H; Balik V; Vrbkova J; Rehulkova A; Vaverka M; Hrabalek L; Ehrmann J; Vidlarova M; Gurska S; Hajduch M; Srovnal J
    Neurosurgery; 2020 Oct; 87(5):1055-1063. PubMed ID: 32125436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular biological determinations of meningioma progression and recurrence.
    Linsler S; Kraemer D; Driess C; Oertel J; Kammers K; Rahnenführer J; Ketter R; Urbschat S
    PLoS One; 2014; 9(4):e94987. PubMed ID: 24722350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A microRNA expression signature predicts meningioma recurrence.
    Zhi F; Zhou G; Wang S; Shi Y; Peng Y; Shao N; Guan W; Qu H; Zhang Y; Wang Q; Yang C; Wang R; Wu S; Xia X; Yang Y
    Int J Cancer; 2013 Jan; 132(1):128-36. PubMed ID: 22674195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early recurrences in histologically benign/grade I meningiomas are associated with large tumors and coexistence of monosomy 14 and del(1p36) in the ancestral tumor cell clone.
    Maillo A; Orfao A; Espinosa AB; Sayagués JM; Merino M; Sousa P; Lara M; Tabernero MD
    Neuro Oncol; 2007 Oct; 9(4):438-46. PubMed ID: 17704362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic changes with prognostic value in histologically benign meningiomas.
    Barbera S; San Miguel T; Gil-Benso R; Muñoz-Hidalgo L; Roldan P; Gonzalez-Darder J; Cerda-Nicolas M; Lopez-Gines C
    Clin Neuropathol; 2013; 32(4):311-7. PubMed ID: 23442303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratumoral patterns of clonal evolution in meningiomas as defined by multicolor interphase fluorescence in situ hybridization (FISH): is there a relationship between histopathologically benign and atypical/anaplastic lesions?
    Sayagués JM; Tabernero MD; Maíllo A; Espinosa A; Rasillo A; Díaz P; Ciudad J; López A; Merino M; Gonçalves JM; Santos-Briz A; Morales F; Orfao A
    J Mol Diagn; 2004 Nov; 6(4):316-25. PubMed ID: 15507670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The correlation of clinical and chromosomal alterations of benign meningiomas and their recurrences.
    Och W; Szmuda T; Kulbacki K; Witek K; Sikorska B; Zakrzewska M; Springer J; Reszeć J; Parda A; Liberski PP
    Neurol Neurochir Pol; 2016; 50(6):395-402. PubMed ID: 27480481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of 1p in recurrent meningiomas. a comparative study in successive recurrences by cytogenetics and fluorescence in situ hybridization.
    López-Ginés C; Cerdá-Nicolás M; Gil-Benso R; Barcia-Salorio JL; Llombart-Bosch A
    Cancer Genet Cytogenet; 2001 Mar; 125(2):119-24. PubMed ID: 11369054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and prognostic significance of genetic regional heterogeneity in meningiomas.
    Pfisterer WK; Hank NC; Preul MC; Hendricks WP; Pueschel J; Coons SW; Scheck AC
    Neuro Oncol; 2004 Oct; 6(4):290-9. PubMed ID: 15494096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-200a-mediated suppression of non-muscle heavy chain IIb inhibits meningioma cell migration and tumor growth in vivo.
    Senol O; Schaaij-Visser TB; Erkan EP; Dorfer C; Lewandrowski G; Pham TV; Piersma SR; Peerdeman SM; Ströbel T; Tannous B; Saydam N; Slavc I; Knosp E; Jimenez CR; Saydam O
    Oncogene; 2015 Apr; 34(14):1790-8. PubMed ID: 24858044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of chromosome 1p deletion using FISH on meningioma touch imprints suggest a region outside chromosome 22 as important in tumor recurrence.
    Tamiolakis D; Papadopoulos N; Lambropoulou M; Kotini A; Simopoulos C
    Minerva Med; 2003 Feb; 94(1):51-6. PubMed ID: 12719702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent cytogenetic aberrations in histologically benign, invasive meningiomas of the sphenoid region.
    Korshunov A; Cherekaev V; Bekyashev A; Sycheva R
    J Neurooncol; 2007 Jan; 81(2):131-7. PubMed ID: 16850103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromosome 1p and 14q FISH analysis in clinicopathologic subsets of meningioma: diagnostic and prognostic implications.
    Cai DX; Banerjee R; Scheithauer BW; Lohse CM; Kleinschmidt-Demasters BK; Perry A
    J Neuropathol Exp Neurol; 2001 Jun; 60(6):628-36. PubMed ID: 11398839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological variables, immunophenotype, chromosome 1p36 loss and tumour recurrence of 247 meningiomas grade I and II.
    Ruiz J; Martínez A; Hernández S; Zimman H; Ferrer M; Fernández C; Sáez M; López-Asenjo JA; Sanz-Ortega J
    Histol Histopathol; 2010 Mar; 25(3):341-9. PubMed ID: 20054806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allelic losses at 1p, 9q, 10q, 14q, and 22q in the progression of aggressive meningiomas and undifferentiated meningeal sarcomas.
    Lamszus K; Kluwe L; Matschke J; Meissner H; Laas R; Westphal M
    Cancer Genet Cytogenet; 1999 Apr; 110(2):103-10. PubMed ID: 10214357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allelic loss at 1p is associated with tumor progression of meningiomas.
    Bello MJ; de Campos JM; Kusak ME; Vaquero J; Sarasa JL; Pestaña A; Rey JA
    Genes Chromosomes Cancer; 1994 Apr; 9(4):296-8. PubMed ID: 7519053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of material from chromosome arm 1p during malignant progression of meningioma revealed by fluorescent in situ hybridization.
    Ishino S; Hashimoto N; Fushiki S; Date K; Mori T; Fujimoto M; Nakagawa Y; Ueda S; Abe T; Inazawa J
    Cancer; 1998 Jul; 83(2):360-6. PubMed ID: 9669820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of chromosome 1p and loss of expression of alkaline phosphatase indicate progression of meningiomas.
    Müller P; Henn W; Niedermayer I; Ketter R; Feiden W; Steudel WI; Zang KD; Steilen-Gimbel H
    Clin Cancer Res; 1999 Nov; 5(11):3569-77. PubMed ID: 10589773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.